Hydrogenology
Hydrogenology editorial study record

Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier

Ge L, Qi J, Shao B, Ruan Z, Ren Y, Sui S, Wu X, Sun X, Liu S, Li S, Xu C, Song W. · 2022.

PreclinicalOther formsPublished 2022
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled mouse and tissue study

Research topic

Gastrointestinal health

Administration classification

Other forms

Study result signal

Positive preclinical signal.

Outcome type

Animal disease, tissue-barrier, microbiome and metabolic outcomes.

Reported in the source

Methods at a glance

Population or model

Mice with dextran-sulfate-sodium-induced colitis and associated colon-tissue analyses.

Sample

Mouse groups and assay-specific subsamples were checked; the article does not give one consolidated total across all experiments.

Duration

17-day protocol, with colitis induction during the final week.

Intervention

Intraperitoneal hydrogen-rich saline throughout the experimental period.

Hydrogen form

H₂ dissolved in saline.

H₂ specification

The checked article reports preparation and repeated dosing; no dose is inferred beyond its methods.

H₂ flow

Not applicable.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Control, vehicle, colitis and colitis-plus-hydrogen-saline groups.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Colitis severity, intestinal barrier structure, microbiota, short-chain fatty acids and colonocyte metabolism.

Reported result

The hydrogen-saline group was reported to have less experimental colitis and better barrier-related, microbiome and metabolic measures than untreated colitis controls.

Results-extraction completeness

The full article was checked for methods, intervention details, outcomes, positive and null findings, funding and conflicts. This record does not imply medical efficacy.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Animal and mechanistic microbiome evidence only; numerous correlated endpoints and unclear blinded assessment.

Applies directly to

The reported DSS mouse-colitis model only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Controlled groups were used, while concealment, assessor blinding and multiplicity handling were not fully established.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 35025709 · DOI: 10.1080/19490976.2021.2013764

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed Central full article and PubMed bibliographic record; source identity, methods, intervention, results, funding and conflicts checked 10 August 2026.

Record revision

2026-08-10